Oxford BioMedica/Sanofi Make Headway With FDA On TroVax Cancer Vaccine
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug makers reaffirm commitment to developing TroVax, a therapeutic vaccine for renal cancer and potentially colorectal cancer.